Journal of Food and Nutrition Research
ISSN (Print): 2333-1119 ISSN (Online): 2333-1240 Website: http://www.sciepub.com/journal/jfnr Editor-in-chief: Prabhat Kumar Mandal
Open Access
Journal Browser
Go
Journal of Food and Nutrition Research. 2016, 4(9), 615-620
DOI: 10.12691/jfnr-4-9-9
Open AccessArticle

Effect of Lupinus albus on Glycaemic Control, Plasma Insulin Levels, Lipid Profile and Liver Enzymes in Type 2 Diabetics

Rim Bouchoucha1, 2, , Mohamed Kacem Ben Fradj3, Mongia Bouchoucha4, Mouna Akrout4, Moncef Feki3, Naziha Kaabachi3, Aly Raies2 and Hedia Slimane1

1Service of Endocrinology-Diabetology, Rabta Hospital, Faculty of Medicine of Tunis, Jebbari, 1007 Tunis, Tunis El Manar University, Tunisia

2Laboratory of Active Biomolecules and Microorganisms, Faculty of Sciences of Tunis, 2092 Tunis, Tunis El Manar University, Tunisia

3Laboratory of Biochemistry, Rabta Hospital, Faculty of Medicine of Tunis, Jebbari, 1007 Tunis, Tunis El Manar University, Tunisia

4National Institute of Health Sciences and Technologies of Tunis, Jebbari, 1007 Tunis, Tunis El Manar University, Tunisia

Pub. Date: September 12, 2016

Cite this paper:
Rim Bouchoucha, Mohamed Kacem Ben Fradj, Mongia Bouchoucha, Mouna Akrout, Moncef Feki, Naziha Kaabachi, Aly Raies and Hedia Slimane. Effect of Lupinus albus on Glycaemic Control, Plasma Insulin Levels, Lipid Profile and Liver Enzymes in Type 2 Diabetics. Journal of Food and Nutrition Research. 2016; 4(9):615-620. doi: 10.12691/jfnr-4-9-9

Abstract

Lupinus species and their derivatives are good candidates to be used as hypoglycaemic agents. The aim of this study was to evaluate the effects of supplementation with Lupinus albus dry extract in type 2 diabetic patients. The study included 47 adult patients (21 men and 26 women) with type 2 diabetes. While consuming their usual medication, patients received a daily dose of 400 mg of Lupinus albus dry extract during 12 weeks. Fasting and post meal test glucose and insulin were measured at baseline and after 2 and 12 weeks. Plasma lipids, Alanine and Aspartate aminotransferases activities and glycated haemoglobin were assessed at baseline and at the end of the supplementation period. Compared to baseline values, fasting and postprandial plasma glucose levels were decreased at 2 and 12 weeks. Blood glucose area under the curve significantly decreased after 2 weeks (p<0.01) and 12 weeks (p<0.05) of lupine administration. Fasting insulin concentrations (10.3±5.34 vs. 11.9±6.58; p<0.05) and homeostasis model assessment of insulin resistance (3.50±2.01 vs. 4.40±2.80; p<0.01) were significantly lower at 12 weeks, but not at 2 weeks. The area under the curve for insulin response did not differ from the baseline. After 12 weeks of Lupinus albus administration, glycated haemoglobin (-5.71%), plasma total cholesterol (-8.12%), LDL cholesterol (-5%), triglycerides (-23.2%), and Alanine aminotransferase activity (-21.1%) were significantly decreased compared to baseline. The study showed that administration of Lupinus albus results in a hypoglycaemic effect and an improvement of diabetes control, but does not affect insulin secretion. These findings suggest that Lupinus albus has insulin mimetic action.

Keywords:
Blood glucose Glycated haemoglobin Insulin Lupinus albus Type 2 diabetes mellitus

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]  Whiting, D.R., Guariguata, L., Weil, C., Shaw, J, IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract., 94, 311-321, 2011.
 
[2]  Bouguerra, R., Alberti, H., Salem, L.B., Rayana, C.B., Atti, J.E., Gaigi, S., Salama, C.B., Zouari, B., Alberti, K, The global diabetes pandemic: the Tunisian experience. Eur J Clin Nutr., 61, 160-165, 2007.
 
[3]  Ben Romdhane, H., Ben Ali, S., Aissi, W., Traissac, P., Aounallah-Skhiri, H., Bougatef, S., et al. Prevalence of diabetes in northern African countries: the case of Tunisia. BMC Public Health., 14, 86, 2014.
 
[4]  Stein, S.A., Lamos, E.M., Davis, S.N. A review of the efficacy and safety of oral antidiabetic drugs. Expert Opin Drug Saf., 12, 153-175, 2013.
 
[5]  Salimifar, M., Fatehi-Hassanabad, Z., Fatehi, M. A review on natural products for controlling type 2 diabetes with an emphasis on their mechanisms of actions. Curr Diabetes Rev., 9, 402-411, 2013.
 
[6]  Kinder, D.H, Knecht, K.T. Lupine (Lupinus caudatus L., Lupinus albus L.) Seeds: History of Use, Use as an Antihyperglycemic Medicinal, and Use as a Food. In Preedy VR, Watson RR and. Patel VB. eds. Nuts and Seeds in Health and Disease Prevention, Elsevier. Pages 711-716, 2011.
 
[7]  Lucas, M.M., Stoddard, F.L., Annicchiarico, P., Frías, J., Martínez-Villaluenga, C., Sussmann, D., et al. The future of lupin as a protein crop in Europe. Front Plant Sci., 8, 705, 2015.
 
[8]  Bertoglio, J.C., Calvo, M.A, Hancke, J.L., Burgos, R.A., Riva, A., Morazzoni, P., et al. Hypoglycemic effect of lupin seed γ-conglutin in experimental animals and healthy human subjects. Fitoterapia., 82, 933-938, 2011.
 
[9]  Lovati, M.R., Manzoni, C., Castiglioni, S., Parolari, A., Magni, C., Duranti, M, Lupin seed γ conglutin lowers blood glucose in hyperglycaemic rats and increases glucose consumption of HepG2 cells. Br J Nutr., 107, 67-73.
 
[10]  Magni, C., Sessa, F., Accardo, E., Vanoni, M., Morazzoni, P., Scarafoni, A., et al. Conglutin gamma, a lupin seed protein, binds insulin in vitro and reduces plasma glucose levels of hyperglycemic rats. J Nutr Biochem., 15, 646-650, 2004.
 
[11]  Terruzzi, I., Senesi, P., Magni, C., Montesano, A., Scarafoni, A., Luzi, L., et al. Insulin-mimetic action of conglutin-γ, a lupin seed protein, in mouse myoblasts. Nutr Metab Cardiovasc Dis., 21, 197-205, 2011.
 
[12]  Hamza, N., Berke, B., Cheze, C., Le Garrec, R., Lassalle, R., Agli, A.N., et al. Treatment of high fat diet induced type 2 diabetes in C57BL/6J mice by two medicinal plants used in traditional treatment of diabetes in the east of Algeria. J Ethnopharmacol., 133, 931-933, 2011.
 
[13]  Komatsu, S., Hirano, H, Plant basic 7 S globulin-like proteins have insulin and insulin-like growth factor binding activity. FEBS Lett., 294, 210-212, 1991.
 
[14]  Dove, E.R., Mori, T.A., Chew, G.T., Barden, A.E, Woodman, R.J., Puddey, I.B, et al. Lupin and soya reduce glycaemia acutely in type 2 diabetes. Br J Nutr., 106, 1045-1051, 2011.
 
[15]  World Health Organization, Definition, diagnosis, and classification of diabetes mellitus and its complications. Part 1. Diagnosis and classification of diabetes mellitus, World Health Organization, Geneva, 1999.
 
[16]  American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care., 34 (Supplement 1), S62-S69, 2011.
 
[17]  Wolever, T.M., Jenkins, D.J, Ocana, A.M., Rao, V.A., Collier, G.R. Second-meal effect: low-glycemic-index foods eaten at dinner improve subsequent breakfast glycemic response. Am J Clin Nutr., 48, 1041-1047, 1988.
 
[18]  Friedewald, W.T., Levy, R.I., Fredrickson, D.S, Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, without use of the preparative ultracentrifuge. Clin Chem., 18, 499-502, 1972.
 
[19]  Mansour, H.A., Newairy, A.S., Yousef, M.I., Sheweita, S.A, Biochemical study on the effects of some Egyptian herbs in alloxan-induced diabetic rats. Toxicology., 170, 221-228, 2002.
 
[20]  Sharma, R.D., Sarkar, A., Hazra, D.K., Mishra, B., Singh, J.B., Sharma SK, et al. Use of fenugreek seed powder in the management of non-insulin dependent diabetes mellitus. Nutr Res., 16, 1331-1339, 1996.
 
[21]  Neelakantan, N., Narayanan, M., de Souza, R.J., Van Dam, R.M, Effect of fenugreek (Trigonella foenumgraecum L) intake on glycemia: a meta-analysis of clinical trials. Nutr J., 13, 1-11, 2014.
 
[22]  Watkins, P.J, ABC of diabetes: Cardiovascular disease, hypertension, and lipids. BMJ., 326, 874-876, 2003.
 
[23]  Bähr, M., Fechner, A., Krämer, J., Kiehntopf, M., Jahreis, G, Lupin protein positively affects plasma LDL cholesterol and LDL:HDL cholesterol ratio in hypercholesterolemic adults after four weeks of supplementation: a randomized, controlled crossover study. Nutr J., 12, 107, 2013.
 
[24]  Martins, J.M., Riottot, M., de Abreu, M.C., Viegas-Crespo, A.M., Lança, M.J., Almeida, J.A., et al. Cholesterol-lowering effects of dietary blue lupin (Lupinus angustifolius L.) in intact and ileorectal anastomosed pigs. J Lipid Res., 46, 1539-1547, 2005.
 
[25]  Marchesi, M., Parolini, C., Diani, E., Rigamonti, E., Cornelli, L., Arnoldi, A., Sirtori CR., et al. Hypolipidaemic and anti-atherosclerotic effects of lupin proteins in a rabbit model. Br J Nutr., 100, 707-710, 2008.
 
[26]  Fontanari, G.G., Batistuti, J.P., da Cruz, R.J., Saldiva, P.H.N., Arêas, J.A.G. Cholesterol-lowering effect of whole lupin (Lupinus albus) seed and its protein isolate. Food Chemistry., 132, 1521-1526, 2012.
 
[27]  Sewani-Rusike, C.R., Jumbam, D.N., Chinhoyi, L.R., Nkeh-Chungag, B.N, Investigation of hypoglycemic and hypolipidemic effects of an aqueous extract of lupinus albus legume seed in streptozotocin- induced type 1 diabetic rats. Afr J Tradit Complement Altern Med.,12, 36-42, 2015.
 
[28]  Viveros, A., Centeno, C., Arija, I., Brenes, A, Cholesterol-lowering effects of dietary lupin (Lupinus albus var. multolupa) in chicken diets. Poult Sci., 86, 2631-2638, 2007.
 
[29]  Sirtori, C.R., Lovati, M.R., Manzoni, C., Castiglioni, S., Duranti, M., Magni, C., et al. Proteins of white lupin seed, a naturally isoflavone-poor legume, reduce cholesterolemia in rats and increase LDL receptor activity in HepG2 cells. J Nutr., 134, 18-23, 2004.
 
[30]  Costa, N.M., Low, A.G., Walker, A.F., Owen, R.W., Englyst, H.N, Effect of baked beans (Phaseolus vulgaris) on steroid metabolism and non-starch polysaccharides output of hypercholesterolaemic pigs with or without an ileo-rectal anastomosis. Br J Nutr., 71, 871-886, 1994.
 
[31]  Yoshie-Stark, Y., Wäsche, A, In vitro binding of bile acids by lupin protein isolates and their hydrolysates. Food Chemistry., 88, 179-184, 2004.
 
[32]  Harisa, G.I., Alanazi, F.K, The beneficial roles of Lupineus luteus and lifestyle changes in management of metabolic syndrome: A case study. Saudi Pharm J., 23, 712-715, 2015.
 
[33]  Osman, M., Mahmoud, G.I., Romeilah, R.M., Fayed, S.A, Lupin seeds lower plasma lipid concentrations and normalize antioxidant parameters in rats. Grasas y Aceites., 62, 162-170, 2011.
 
[34]  El-Dakak, A., Abd El-Rahman, H., El-Nahal, D, Comparison studies between aqueous lepidium sativum L., lupinus albus and trigonella foenum-gracum seeds, and their mixture extracts on streptozotocin-induced diabetic rats. Journal of Applied Sciences Research., 9, 2965-2982, 2013.
 
[35]  Reinhard, H., Rupp, H., Sager, F., Streule, M., Zoller, O, Quinolizidine alkaloids and phomopsins in lupin seeds and lupin containing food, J. Chromatogr. A., 1112, 353-360, 2006.
 
[36]  Wasche, A., Muller, K., Knauf, U, New processing of lupin protein isolates and functional properties. Nahrung/Food., 45, 393-395, 2001.